Special Drug Use Investigation of Glucobay OD

Bayer

Status: Completed

Conditions: Diabetes Mellitus

Treatments: Drug: Glucobay ODT (Acarbose, BAYG5421)

Study type: Observational

Funder types: Industry

Identifiers

NCT01685502

Glucobay OD (Other Identifier)

16517

Details and patient eligibility

About

The objective of this study is to assess the efficacy and safety under practical use of Glucobay OD. A total of 5,000 patients are to be enrolled to the study and assessed during 1 year observation period.

Enrollment: 2,289 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Glucobay OD naive diabetics. patients with at least one of the following conditions: Uncontrollable with dietary therapy,exercise cure, diabetes medication, insulin therapy.

Exclusion criteria

• Patients who are contraindicated based on the product label

Trial design

2,289 participants in 1 patient group

Group 1

Description:

Patients treated with Glucobay OD under practical manner

Treatment:

Drug: Glucobay ODT (Acarbose, BAYG5421)